FDA issues warning letters to companies illegally selling CBD and Delta-8 THC products

Source: FDA Newsroom

May 13, 2022 | Clinical Developments, Policy

Today, the U.S. Food and Drug Administration issued warning letters to five companies for selling products labeled as containing delta-8 tetrahydrocannabinol (delta-8 THC) in ways that violate the Federal Food, Drug, and Cosmetic Act (FD&C Act). This action is the first time the FDA has issued warning letters for products containing delta-8 THC. Delta-8 THC has psychoactive and intoxicating effects and may be dangerous to consumers. The FDA has received reports of adverse events experienced by patients who have consumed these products.

Archives

Click here to learn how STEM selects new articles.